Skip to content

Author

C. Diorio

We have 4 of 305 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

[Effects of phytoestrogens on prognosis and hormonal markers of breast cancer: A systematic review of randomized controlled trials].

INTRODUCTION Estrogen exposure is a known risk factor for breast cancer. Phytoestrogens, plant-derived compounds found in the diet, have a structure similar to estradiol. Observational studies suggest that they are associated with a reduced risk of breast cancer recurrence. The objective of this systematic review is to...

Laurence Poirier, C. Diorio · 0 citations
Aug 2026

T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.

Ibrutinib improved proliferative fitness, attenuated senescence-associated features and SASP output in paired patient and direct-exposure assays, and enhanced CAR T-cell expansion in an ibrutinib-resistant CLL model.

Julia Han Noll, Devin Dersh, Jiang-Yuan Li et al. · 0 citations
Review Sep 2026

Abstract IA03: Immune Related Toxicities Associated with Immunotherapies

Chimeric antigen receptor T-cell (CART) therapy has revolutionized care for many pediatric cancers, especially relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). Although CART are highly effective, they can induce severe toxicities. The most common severe adverse events associated with CART are cytok...

C. Diorio · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.